Vascular calcification and 25-hydroxyvitamin D levels in non-dialysis patients with chronic kidney disease stages 4 and 5

Nephrology Dialysis Transplantation

Volumn 26, Issue 7, 2011, Pages 2250-2256

  García Canton, Cesar ^a   Bosch, Elvira ^a   Ramírez, Ana ^a   Gonzalez, Yeray ^a   Auyanet, Ingrid ^a   Guerra, Rita ^a   Perez, Miguel A ^a   Fernndez, Ernesto ^a   Toledo, Agustn ^a   Lago, Mar ^a   Checa, Maria D ^a  

^a HOSPITAL UNIVERSITARIO INSULAR DE GRAN CANARIA   (Spain)

Author keywords

25 hydroxyvitamin D; cardiovascular disease; chronic kidney disease; vascular calcification

Indexed keywords

25 HYDROXYVITAMIN D;

ADULT; AGE; AGED; ARTERY CALCIFICATION; ARTICLE; BLOOD VESSEL CALCIFICATION; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; HAND RADIOGRAPHY; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PELVIS RADIOGRAPHY; PREVALENCE; PRIORITY JOURNAL; SPINE RADIOGRAPHY; VITAMIN BLOOD LEVEL;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CALCINOSIS; CARDIOVASCULAR DISEASES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; PROGNOSIS; RISK FACTORS; VASCULAR DISEASES; VITAMIN D; YOUNG ADULT;

EID: 79959993861     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq650     Document Type: Article

References (53)

1. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization. N Engl J Med 2004; 351: 1296-1305.
2. Goodman WG, London G, Amann K et al. Vascular Calcification Work Group. Vascular calcification in chronic kidney disease. Am J Kidney Dis 2004; 43: 572-579. (Pubitemid 38298218)
3. Giachelli CM. Vascular calcification mechanisms. J Am Soc Nephrol 2004; 15: 2959-2964. (Pubitemid 39578826)
4. London GM, Marchais SJ, Gu-in AP et al. Arteriosclerosis, vascular calcifications and cardiovascular disease in uremia. Curr Opin Nephrol Hypertens 2005; 14: 525-531. (Pubitemid 41531842)
5. Moe SM, Chen NX. Mechanisms of vascular calcification in chronic kidney disease. J Am Soc Nephrol 2009; 19: 213-216. (Pubitemid 351240642)
6. Card? A, Panizo S, Parisi E et al. Differential effects of vitamin D analogs on vascular calcification. J Bone Miner Res 2007; 22: 860-866. (Pubitemid 351339746)
7. Melamed ML, Michos ED, Post Wet al. 25-Hydroxyvitamin D levels and the risk of mortality in the general population. Arch Intern Med 2008; 168: 1629-1637.
8. Mehrotra R, Kermah D, Salusky IB et al. Chronic kidney disease, hypovitaminosis D and mortality in the United States. Kidney Int 2009; 76: 977-983.
9. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007; 18: 41-46. (Pubitemid 46090236)
10. Adragao T, Pires A, Lucas C et al. A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1480-1488. (Pubitemid 38786742)
11. Kauppila LI, Polak JF, Cupples LA et al. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997; 132: 245-250. (Pubitemid 27311017)
12. Adragao T, Pires A, Birne R et al. A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 2009; 24: 997-1002.
13. Bellasi A, Ferramosca E, Muntner P et al. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006; 70: 1623-1628. (Pubitemid 44606998)
14. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis 2003; 42: 1-202.
15. London G, Guerin AP, Marchais SJ et al. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740. (Pubitemid 37098542)
16. Sigrist M, Bungay P, Taal MWet al. Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714. (Pubitemid 43372919)
17. Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009; 20: 1453-1464.
18. Russo D, Miranda I, Ruocco C et al. The progression of coronary artery calcification in predialysis patients on calcium carbonate or sevelamer. Kidney Int 2007; 72: 1255-1261. (Pubitemid 350059663)
19. Garland JS, Holden RM, Groome PA et al. Prevalence and associations of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008; 52: 849-858.
20. Adeney KL, Siscovick DS, Ix JH et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20: 381-387.
21. Blacher J, Guerin AP, Pannier B et al. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001; 38: 938-942. (Pubitemid 34258697)
22. Wong ND, Hsu JC, Detrano RC et al. Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol 2000; 86: 495-498.
23. Moe SM, O'Neill KD, Fineberg N et al. Assessment of vascular calcification in ESRD patients using spiral CT. Nephrol Dial Transplant 2003; 18: 1152-1158. (Pubitemid 36722518)
24. Wilson PW, Kauppila LI, O'Donel CJ et al. Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103: 1529-1534. (Pubitemid 32226260)
25. Honkanen E, Kauppila L, Wikstr? B et al. Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008; 23: 4009-4015.
26. Cannata-Andia JB, Rodriguez-Garcia M, Carrillo-Lopez N et al. Vascular calcifications: pathogenesis, management, and impact on clinical outcomes. J Am Soc Nephrol 2006; 17: s267-s273. (Pubitemid 44865260)
27. Dellegrottaglie S, Sanz J, Rajagopalan S. Vascular calcification in patients with chronic kidney disease. Blood Purif 2006; 24: 56-62. (Pubitemid 41820823)
28. Giachelli GM. The emerging role of phosphate in vascular calcification. Kidney Int 2009; 75: 890-897.
29. Mizobuchi M, Ogata H, Hatamura I et al. Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism. Nephrol Dial Transplant 2006; 21: 911-916.
30. Qunibi WY, Nolan CA, Ayus JC. Cardiovascular calcification in patients with end-stage renal diseases: a century-old phenomenon. Kidney Int 2002; 62: s73-s80. (Pubitemid 35357001)
31. Raggi P, Kleerekoper M. Contribution of bone and mineral abnormalities to cardiovascular disease in patients with chronic kidney disease. Clin Am J Soc Nephrol 2008; 3: 836-843.
32. Niederhoffer N, Lartaud-Idjouadiene I, Giummelly P et al. Calcification of medial elastic fibers and aortic elasticity. Hypertension 1997; 29: 999-1006. (Pubitemid 27152472)
33. Bas A, Lopez I, Perez J et al. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006; 21: 484-490.
34. Guerin AP, London GM, Marchais SJ et al. Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 2000; 15: 1014-1021. (Pubitemid 30410374)
35. Wolisi GO, Moe SM. The role of vitamin D in vascular calcification in chronic kidney disease. Sem Dialysis 2005; 18: 307-314. (Pubitemid 41159582)
36. London GM, Marchais SJ, Gu-in AP et al. Association of bone activity, calcium load, aortic stiffness and calcifications in ESRD. J Am Soc Nephrol 2008; 19: 1827-1835.
37. de Boer IH, Kestenbaum B, Shoben AB et al. 25-Hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification. J Am Soc Nephrol 2009; 20: 1805-1812.
38. Artaza JN, Mehrotra R, Norris KC. Vitamin D and the cardiovascular system. Clin J Am Soc Nephrol 2009; 4: 1515-1522.
39. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266-281.
40. Forman JP, Giovannucci E, Holmes MD et al. Plasma 25-hydroxyvitamin D levels and risk of incident hypertension. Hypertension 2007; 49: 1063-1069. (Pubitemid 351664326)
41. Dobnig H, Pilz S, Scharnagl H et al. Independent association of low serum 25-hydroxyvitamin D and 1, 25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008; 168: 1340-1349. (Pubitemid 351930842)
42. Gonzalez E, Sachdeva A, Oliver D et al. Vitamin D insufficiency and deficiency in chronic kidney disease. A single center observational study. Am J Nephrol 2004; 24: 503-510. (Pubitemid 39656665)
43. Mehrotra R, Kermah D, Budoff M et al. Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol 2008; 3: 1144-1151.
44. Wolf M, Shah A, Gutierrez O et al. Vitamin D levels and early mortality among incident hemodialysis patients. Kidney Int 2007; 72: 1004-1013. (Pubitemid 47530570)
45. Matias PJ, Ferreira C, Jorge C et al. 25-Hydroxyvitamin D3, arterial calcifications and cardiovascular risk markers in haemodialysis patients. Nephrol Dial Transplant 2009; 24: 611-618.
46. London GM, Guerin AP, Verbeke FH et al. Mineral metabolism and arterial functions in end-stage renal disease: potential role of 25-hydroxyvitamin D deficiency. J Am Soc Nephrol 2007; 18: 613-620. (Pubitemid 46193327)
47. Conchol M, Cigolini M, Targher G. Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction. Nephrol Dial Transplant 2008; 23: 269-274. (Pubitemid 351767364)
48. Kalantar-Zadeh K, Kuwae N, Regidor DL et al. Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients. Kidney Int 2006; 70: 771-780. (Pubitemid 44215354)
49. Tentori F, Hunt WC, Stidley CA et al. Mortality risk among hemodialysis patients receiving different vitamin D analogs. Kidney Int 2006; 70: 1858-1865. (Pubitemid 44684819)
50. Teng M, Wolf M, Lowrie E et al. Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy. N Engl J Med 2003; 349: 446-456. (Pubitemid 36910023)
51. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009; 76: S1-S130.
52. Al-Badr W, Martin KJ. Vitamin D and kidney disease. Clin J Am Soc Nephrol 2008; 3: 1555-1560.
53. Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol 2008; 3: 1535-1541